Live Feeds

Source map — Eli Lilly blows past estimates, hikes sales outlook on resilient Zepbound and Mounjaro demand

Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.

SourceTypeTrust
CNBC news 60%
Eli Lilly news 60%
Yahoo Finance news 60%
Bloomberg news 60%
WSJ news 60%
www.cnbc.com news 50%
finance.yahoo.com news 50%
global.svn.com news 50%